All entries for: BirchBioMed Inc.

November 14, 2025

BirchBioMed Inc.

Orphan Drug Designation

FDA orphan drug designation: treatment of idiopathic pulmonary fibrosis (IPF)

Disease Area: Rare Diseases
Scroll to Top